Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
South African
100%
Hepatitis B Virus
100%
African Patient
100%
Human Immunodeficiency Virus Infection
100%
Anti-HBc
30%
CD4+
23%
Cell Count
23%
Hepatitis B Surface Antigen (HBsAg)
23%
Virus Prevalence
23%
Serology
15%
Sub-Saharan Africa
7%
Major Risk
7%
Antiretroviral
7%
Molecular Characteristics
7%
Polymerase Chain Reaction
7%
Co-infection
7%
Viral Load
7%
Occult Hepatitis B Virus Infection
7%
Negative Control
7%
Developing Countries
7%
AIDS Patients
7%
Public Health Impact
7%
Molecular Detection
7%
Hepatitis B Core-related Antigen
7%
As(III)
7%
Hepatitis B Virus Replication
7%
Occult Hepatitis B Virus
7%
Anti-HBs Titre
7%
Virus Polymerase
7%
Viral Load Monitoring
7%
Serological Characteristics
7%
CD4 Cell Count
7%
Human Immunodeficiency Virus-negative
7%
Serological Pattern
7%
Immunology and Microbiology
Hepatitis B Virus
100%
Coinfection
100%
Human Immunodeficiency Virus
100%
Acquired Immune Deficiency Syndrome
100%
Hepatitis B Core Antibody
33%
Prevalence
26%
CD4 Lymphocyte Count
26%
Viral Load
13%
HBsAg
13%
Hepatitis B Antigen
13%
Hepatitis B Surface Antibody
13%
Serology
13%
Hepatitis B
6%
Human Immunodeficiency Virus Infection
6%
Viral Replication
6%
Polymerase Chain Reaction
6%